Sefal Pharmaceutics Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.45 M
- Company Age 25 Year, 11 Months
- Last Filing with ROC 31 Mar 2019
- Satisfied Charges ₹ 0.80 M
- Revenue Growth 14608.92%
- Profit Growth -2393.58%
- Ebitda -1833.48%
- Net Worth -44.98%
- Total Assets -27.74%
About Sefal Pharmaceutics
Company Details
- Location
Sangrur, Punjab, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232PB1999PTC022320
- Company No.
022320
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Mar 1999
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Sefal Pharmaceutics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shaheer Ariz  | Director | 22-Sep-2014 | Current |
| Yashpal Arora | Director | 22-Sep-2014 | Current |
Financial Performance of Sefal Pharmaceutics.
Sefal Pharmaceutics Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 14608.92% increase. The company also saw a substantial fall in profitability, with a 2393.58% decrease in profit. The company's net worth observed a substantial decline by a decrease of 44.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sefal Pharmaceutics?
In 2019, Sefal Pharmaceutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Indisurg (India) Surgicals LlpShaheer Ariz and Yashpal Arora are mutual person
- Rockmed Pharma Private Limited
Shaheer Ariz and Yashpal Arora are mutual person
- Kureasia Pharma Private Limited
Shaheer Ariz and Yashpal Arora are mutual person
- Medifirm Pharmacy Llp
Yashpal Arora is a mutual person
Charges (Loans)
₹0
₹0.80 M
Charges Breakdown by Lending Institutions
- Punjab National Bank : 0.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Oct 2002 | Punjab National Bank | ₹0.80 M | Satisfied |
How Many Employees Work at Sefal Pharmaceutics?
Unlock and access historical data on people associated with Sefal Pharmaceutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sefal Pharmaceutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sefal Pharmaceutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
